And keep this in mind: Like everyone we like praise and encouragement.

FORBES: 6 Ways You Can Help Scoble & Me Write 'Age of Context'

And rather than suggesting it was folly for AstraZeneca to support this study, they should receive public praise and encouragement for taking a risk and putting the key question about the marginal benefit of their product on the table.

FORBES: AstraZeneca Study is Good News for the Public, Bad News for AstraZeneca

Your encouragement, praise and criticism have made us better.

FORBES: Twitter Buys Posterous